Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2015
[Current PMDA Activities for Use of Biomarkers in Drug Evaluation]Akihiro Ishiguro
Journal of Human Genetics|May 10, 2013
Characteristics of pharmacogenomics/biomarker-guided clinical trials for regulatory approval of anti-cancer drugs in JapanAkihiro Ishiguro, Satomi Yagi, Yoshiaki Uyama
Pharmacogenomics|January 19, 2013
Regulatory perspective on remaining challenges for utilization of pharmacogenomics-guided drug developmentsYasuto Otsubo, Akihiro Ishiguro, Yoshiaki Uyama
Drug Metabolism and Pharmacokinetics|January 7, 2020
Development of a new Japanese guideline on drug interaction for drug development and appropriate provision of informationAkihiro Ishiguro, Reiko Sato, Naomi Nagai
Expert Review of Clinical Pharmacology|January 14, 2014
Current Japanese regulatory situations of pharmacogenomics in drug administrationAkihiro Ishiguro, Satoshi Toyoshima, Yoshiaki Uyama
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 18, 2004
A long PCR assay to distinguish CYP2D6*5 and a novel CYP2D6 mutant allele associated with an 11-kb EcoRI haplotypeAkihiro Ishiguro, Takahiro Kubota, Hiroshi Sasaki, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 20, 2004
Metabolic activity of dextromethorphan O-demethylation in healthy Japanese volunteers carrying duplicated CYP2D6 genes: duplicated allele of CYP2D6*10 does not increase CYP2D6 metabolic activityAkihiro Ishiguro, Takahiro Kubota, Hiroshi Ishikawa, et al.
Medicine|June 9, 2025
Granulocyte colony-stimulating factor-producing cutaneous squamous cell carcinoma: A case report and literature reviewAkihiro Ishiguro, Nobuhiko Iwashita, Megumi Otani, et al.
Drug Metabolism and Pharmacokinetics|March 11, 2026
Advances and challenges for drug interaction evaluation - Perspectives on the ICH M12 guidelineXinning Yang, Carolien Versantvoort, Motohiro Hoshino, et al.
Cureus|July 18, 2025
A Case of Umbilical Invasive Extramammary Paget Disease With a High Tumor Mutational Burden Successfully Treated With PembrolizumabAkihiro Ishiguro, Kenichiro Mae, Ryokichi Irisawa, et al.
Pageof 3